Downloads · 30 days
6
19% of all-time downloads
medspaner/mbert-base-clinical-trials-attributes
mbert-base-clinical-trials-attributes is a machine learning model from medspaner. Use it for the machine learning task on the model card, and read the license before you ship it in a product. The card lists the license as cc-by-nc-4.0.
should probably proofread and complete it, then remove this comment. --
Downloads · 30 days
6
19% of all-time downloads
All-time downloads
32
Public
Repo size
709 MB
Likes
0
Public
Click a slice to open those files.
.bin709 MB · 100%
From the Hugging Face model README
This named entity recognition model detects the following types of medical attributes:
Experiencer:
Event temporality:
The model achieves the following results on the test set (results are averaged over 5 evaluation rounds):
This model adapts the pre-trained model bert-base-multilingual-cased, the multilingual version of the BERT model presented in Devlin al. (2019), which was pre-trained on a corpus derived from Wikipedia covering 104 languages. The model is fine-tuned to conduct medical named entity recognition on texts about in Spanish using the CT-EBM-ES corpus (Campillos-Llanos et al. 2021) vs 2.
If you use this model, please, cite as follows:
@article{campillosetal2024,
title = {{Hybrid tool for semantic annotation and concept extraction of medical texts in Spanish}},
author = {Campillos-Llanos, Leonardo and Valverde-Mateos, Ana and Capllonch-Carri{\'o}n, Adri{\'a}n},
journal = {BMC Bioinformatics},
year={2024},
publisher={BioMed Central}
}
Disclosure: This model is under development and needs to be improved. It should not be used for medical decision making without human assistance and supervision
This model is intended for a generalist purpose, and may have bias and/or any other undesirable distortions.
Third parties who deploy or provide systems and/or services using any of these models (or using systems based on these models) should note that it is their responsibility to mitigate the risks arising from their use. Third parties, in any event, need to comply with applicable regulations, including regulations concerning the use of artificial intelligence.
The owner or creator of the models will in no event be liable for any results arising from the use made by third parties of these models.
Descargo de responsabilidad: Esta herramienta se encuentra en desarrollo y no debe ser empleada para la toma de decisiones médicas
La finalidad de este modelo es generalista, y se advierte que puede tener sesgos y/u otro tipo de distorsiones indeseables.
Terceras partes que desplieguen o proporcionen sistemas y/o servicios usando alguno de estos modelos (o utilizando sistemas basados en estos modelos) han tener presente que es su responsabilidad abordar y minimizar los riesgos derivados de su uso. Las terceras partes, en cualquier circunstancia, deben cumplir con la normativa aplicable, incluyendo la normativa que concierne al uso de la inteligencia artificial.
El propietario o creador de los modelos de ningún modo será responsable de los resultados derivados del uso que las terceras partes hagan de estos modelos.
The model is fine-tuned on the Clinical Trials for Evidence-Based-Medicine in Spanish (CT-EBM-SP) corpus vs 2. The CT-EBM-SP corpus is a collection of 1200 texts about clinical trials studies and clinical trials announcements:
If you use the CT-EBM-ES resource, please, cite as follows:
@article{campillosetal-midm2021,
title = {A clinical trials corpus annotated with UMLS© entities to enhance the access to Evidence-Based Medicine},
author = {Campillos-Llanos, Leonardo and Valverde-Mateos, Ana and Capllonch-Carri{\'o}n, Adri{\'a}n and Moreno-Sandoval, Antonio},
journal = {BMC Medical Informatics and Decision Making},
volume={21},
number={1},
pages={1--19},
year={2021},
publisher={BioMed Central}
}
The following hyperparameters were used during training:
| Precision | Recall | F1 | Accuracy |
|---|---|---|---|
| 0.868 (±0.023) | 0.831 (±0.014) | 0.849 (±0.005) | 0.986 (±0.001) |